These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10385553)

  • 1. Corticosteroids in the management of bowel obstruction on a gynecological oncology unit.
    Philip J; Lickiss N; Grant PT; Hacker NF
    Gynecol Oncol; 1999 Jul; 74(1):68-73. PubMed ID: 10385553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative treatment of upper intestinal obstruction by gynecological malignancy: the usefulness of percutaneous endoscopic gastrostomy.
    Campagnutta E; Cannizzaro R; Gallo A; Zarrelli A; Valentini M; De Cicco M; Scarabelli C
    Gynecol Oncol; 1996 Jul; 62(1):103-5. PubMed ID: 8690280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer.
    Chi DS; Phaëton R; Miner TJ; Kardos SV; Diaz JP; Leitao MM; Gardner G; Huh J; Tew WP; Konner JA; Sonoda Y; Abu-Rustum NR; Barakat RR; Jaques DP
    Oncologist; 2009 Aug; 14(8):835-9. PubMed ID: 19684071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series.
    Caceres A; Zhou Q; Iasonos A; Gerdes H; Chi DS; Barakat RR
    Gynecol Oncol; 2008 Mar; 108(3):482-5. PubMed ID: 18190953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction.
    Shima Y; Ohtsu A; Shirao K; Sasaki Y
    Jpn J Clin Oncol; 2008 May; 38(5):354-9. PubMed ID: 18490369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.
    Feuer DJ; Broadley KE
    Cochrane Database Syst Rev; 2000; 2000(2):CD001219. PubMed ID: 10796761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma.
    Pothuri B; Montemarano M; Gerardi M; Shike M; Ben-Porat L; Sabbatini P; Barakat RR
    Gynecol Oncol; 2005 Feb; 96(2):330-4. PubMed ID: 15661217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide in the management of bowel obstruction in terminal ovarian cancer.
    Mangili G; Franchi M; Mariani A; Zanaboni F; Rabaiotti E; Frigerio L; Bolis PF; Ferrari A
    Gynecol Oncol; 1996 Jun; 61(3):345-8. PubMed ID: 8641613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of corticosteroids in palliative care.
    Shih A; Jackson KC
    J Pain Palliat Care Pharmacother; 2007; 21(4):69-76. PubMed ID: 18032321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive pharmacological treatment for reversing malignant bowel obstruction.
    Mercadante S; Ferrera P; Villari P; Marrazzo A
    J Pain Symptom Manage; 2004 Oct; 28(4):412-6. PubMed ID: 15471659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of intestinal obstruction in the late course of malignant disease.
    Aabo K; Pedersen H; Bach F; Knudsen J
    Acta Chir Scand; 1984; 150(2):173-6. PubMed ID: 6202085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of oral gastrografin in postoperative small bowel obstruction.
    Kapoor S; Jain G; Sewkani A; Sharma S; Patel K; Varshney S
    J Surg Res; 2006 Apr; 131(2):256-60. PubMed ID: 16457844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.
    Pothuri B; Meyer L; Gerardi M; Barakat RR; Chi DS
    Gynecol Oncol; 2004 Oct; 95(1):193-5. PubMed ID: 15385131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of malignant bowel obstruction in terminal care--is home care possible?].
    Sasson M; Shvartzman P
    Harefuah; 1998 May; 134(10):757-9, 832. PubMed ID: 10909630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small bowel obstruction: conservative vs. surgical management.
    Williams SB; Greenspon J; Young HA; Orkin BA
    Dis Colon Rectum; 2005 Jun; 48(6):1140-6. PubMed ID: 15906139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intestinal occlusion in cancer].
    Medina-Franco H
    Rev Gastroenterol Mex; 2004 Nov; 69 Suppl 3():100-5. PubMed ID: 16881208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral dexamethasone attenuates Doxil-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies.
    Drake RD; Lin WM; King M; Farrar D; Miller DS; Coleman RL
    Gynecol Oncol; 2004 Aug; 94(2):320-4. PubMed ID: 15297168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative surgery for recurrent bowel obstruction due to advanced ovarian cancer.
    Caprotti R; Bonardi C; Crippa S; Mussi C; Angelini C; Uggeri F
    Minerva Ginecol; 2006 Jun; 58(3):239-44. PubMed ID: 16783296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of malignant intestinal obstruction. A prospective study over 80 cases].
    Arvieux C; Laval G; Mestrallet JP; Stefani L; Villard ML; Cardin N
    Ann Chir; 2005 Sep; 130(8):470-6. PubMed ID: 16084483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer.
    Matulonis UA; Seiden MV; Roche M; Krasner C; Fuller AF; Atkinson T; Kornblith A; Penson R
    J Pain Symptom Manage; 2005 Dec; 30(6):563-9. PubMed ID: 16376743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.